TO EXPOSE SCAMS!
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
The filings are worse than one ply toilet p[aper. Should be a huge sell off tomorrow.
Are they serious? Where are the billions?
General and administrative expenses 3,541,018
Net income $ 17,013
Did you bother reading the financials? Obviously not! Wade dropped 1.5 billion shares as of the last filing. SMH
3/24/2023 New
Issuance 75,000,000 Common $0.00 Yes
Novus Group
(Joseph
Wade)
Conversion of
preferred
stock
UR 4(a)(1)
3/31/2023 New
Issuance 83,000,000 Common $0.00 Yes
Novus Group
(Joseph
Wade)
Conversion of
preferred
stock
UR 4(a)(1)
4/11/2023 New
Issuance 92,000,000 Common $0.00 Yes
Novus Group
(Joseph
Wade)
Conversion of
preferred
stock
UR 4(a)(1)
4/25/2023 New
Issuance
100,000,000 Common $0.00 Yes
Novus Group
(Joseph
Wade)
Conversion of
preferred
stock
UR 4(a)(1)
5/9/2023 New
Issuance
100,000,000 Common $0.00 Yes
Novus Group
(Joseph
Wade)
Conversion of
preferred
stock
UR 4(a)(1)
5/31/2023 Cancelled -26,280
Series C
Preferred n/a n/a
Novus Group
(Joseph
Wade)
converted n/a n/a
6/22/2023 New
Issuance
120,000,000 Common $0.00 Yes Novus Group
(Joseph
Wade)
Conversion of
preferred
stock
UR 4(a)(1)
7/14/2023 New
Issuance
120,000,000 Common $0.00 Yes Novus Group
(Joseph
Wade)
Conversion of
preferred
stock
UR 4(a)(1)
8/31/2023 Cancelled -9,600 Series C
Preferred n/a n/a (not
traded)
Novus Group
(Joseph
Wade)
converted n/a n/a
9/6/2023 New
Issuance
575,000,000 Common $0.00 Yes Brian McLain Services
Rendered
R 4(a)(1)
9/25/2023 Cancelled -4,800
Series C
Preferred n/a n/a (not
traded)
Novus Group
(Joseph
Wade)
converted n/a n/a
9/29/2023 New
Issuance
120,000,000 Common $0.00 Yes Novus Group
(Joseph
Wade)
Conversion of
preferred
stock
UR 4(a)(1)
10/5/2023 Cancelled -4,800 Series C
Preferred n/a n/a (not
traded)
Novus Group
(Joseph
Wade)
converted n/a n/a
10/11/2023 New
Issuance
120,000,000 Common $0.00 Yes Novus Group
(Joseph
Wade)
Conversion of
preferred
stock
UR 4(a)(1)
11/1/2023 Cancelled -8,000 Series C
Preferred n/a n/a (not
traded)
Novus Group
(Joseph
Wade)
converted n/a n/a
https://www.otcmarkets.com/otcapi/company/financial-report/391921/content
Actually made Chicken Scarpariello tonight. The pizza will be for those who, lose their investment.
Thanks!
What shorts?
Joseph Waded Mezey has been scamming since at least 2008! He was given a cease and desist from California then. He was subsequently disbarred by NY.
He knows that if he gives a MM a big block to dump they will dump on both sides. I have seen it happen too many times in the OTC and I have seen Wade do it many times also!
Please note that as of the last filing there were : 6,032,400 preferred sharers out which convert at 25,000 to 1!
That is over 150 billion shares!
So what great business does this shell have?
Good one! Bloodbath tomorrow!
Understanding Suspended Trading
The SEC has the authority to suspend the trading of a security for up to ten trading days to protect investors under Section 12(k) of the Securities Exchange Act of 1934. The SEC will make the decision to do this based on an investigation and will then issue a press release detailing the reason for the suspension. During the ten-day period, the SEC will not comment publicly on the status of the investigation. Once trading in a security is suspended, shares cannot trade until the suspension is lifted or lapses. The suspension time is determined on a case-by-case basis.
2
Suspended trading occurs for many different reasons, including:
A lack of current, accurate, or adequate information about a company, such as when it’s not current in its filing of periodic reports.
Questions about the accuracy of publicly available information, including the contents of recent press releases.
Concerns about trading in the stock, such as insider trading or market manipulation.
The most common reason for a suspension is the lack of current or accurate financial information. In many cases, companies can resolve the issue by submitting the required financial statements to go back into compliance. Less common cases could involve instances of fraud, in which a company could see a longer-term impact from a trading suspension.
Delinquent SEC Reporting
Pink Limited Information
Wade is dumping! LOL
So you can't dispute it is illegal insider information? Thought so.
States the village idiot!
Insider information is regarded as material, non-public information. Trading based on insider information, called insider trading, without filing the appropriate forms with the SEC, is illegal. It is important to note that a person who possesses the information may not necessarily be a person who works for the company
Knowing when the filings are due and someone claiming to know they will be filed by 10 PM tonight is two different scenarios,
That post is claiming insider information.
No ifs ands or buts! It is illegal if true.
OPERATING LOSS (2,565,730 )
Next one to crash and burn?
Yes, Wade dumped!
what we know what was filed in 8-Ks with the SEC when they were going to go into NHMD.
If true why are they not listed in the filings?
On May 31, 2023, JP Energy Partners entered into a contract for the supply of up to 600,000 metric tons of sugar to be delivered to China comprising of two shipments. Ther first shipment is to be up to 250,000 metric tons and the second shipment consists of up to 350,000 metric tons. The contract has a maximum payment of approximately $268,140,000 including all fees and discounts. It's important to note that, to date, no shipments have taken place under this contract and JP energy Group is in the process of finalizing the bank financing for the transaction which is contingent to close on the transaction above.
Furthermore, we were informed that this assignment involved a newly executed agreement for Grade A frozen chicken paws in addition to the previous sugar contract. The new agreement encompasses the procurement of approximately 97,000 metric tons of chicken paws, with a total contract value of around $300 million, inclusive of all associated fees, discounts, and bonuses. The agreement also incorporates an initial trial shipment of approximately 135 metric tons. Following the successful completion of this trial shipment, the agreement outlines a schedule for the remaining 97,000 metric tons to be delivered in 12 monthly shipments.
Volume: 0
This one next to fall?
WNFT
Worldwide NFT Inc.
Expert Market
https://www.otcmarkets.com/stock/WNFT/overview
Where is the filing?
This site can’t be reached
Where are all the ass kissing pumptards now?
George the OTC WHIZZ Sharp shell kicked down to Expert!
WNFT
Worldwide NFT Inc.
Expert Market
https://www.otcmarkets.com/stock/WNFT/overview
This one next? LOL
WNFT
Worldwide NFT Inc.
Expert Market
https://www.otcmarkets.com/stock/WNFT/overview
BULLSHIT! What lies and slander? I am sure Park would love to explain all the P/R's during discovery! SMH!
Main office.
https://www.google.com/maps/[@ userid=79].1463331,3a,75y,175.8h,90t/data=!3m6!1e1!3m4!1s_K066Nt87GTA_nYAwJKNEg!2e0!7i16384!8i8192?entry=ttu
Field office
https://www.google.com/maps/place/1988+Dale+Rd,+Woodland,+PA+16881/[@ userid=78].2994935,174m/data=!3m1!1e3!4m6!3m5!1s0x89cc40067ec34ca1:0x8553a4472ea34376!8m2!3d41.0127813!4d-78.297725!16s%2Fg%2F11c2cg0_24?entry=ttu
Cancer breakthrough! IOVA
https://med.stanford.edu/news/all-news/2024/05/car-t-melanoma.html
Stanford Medicine delivers first FDA-approved cell-based therapy for solid tumors
share
The FDA recently approved the first cell-based therapy — widely used in treating blood cancers — for solid tumors. Stanford Medicine treated the first patient with advanced melanoma.
https://med.stanford.edu/news/all-news/2024/05/car-t-melanoma.html
the flagship and big money maker?????????????????????
Stanford Medicine delivers first FDA-approved cell-based therapy for solid tumors
share
The FDA recently approved the first cell-based therapy — widely used in treating blood cancers — for solid tumors. Stanford Medicine treated the first patient with advanced melanoma.
May 6, 2024 - By Krista Conger
https://med.stanford.edu/news/all-news/2024/05/car-t-melanoma.html
The therapy, called lifileucel and commercially known as Amtagvi, is marketed by San Carlos-based Iovance Biotherapeutics.
Clinical trials of lifileucel for metastatic melanoma that worsened while on standard treatment found that about 30% of 153 patients who received the therapy had their tumors shrink or disappear. Of those, 40% experienced no progression of their cancers for at least 18 months after the one-time infusion.
NO!
The key. a balance sheet and equity statement are since inception. If information is missing, it is impossible to present those statements accurately. Even 1 year's information that is missing can easily cause the financial statements to not be accurate, and therefore not auditable.
Great DD as usual!
Now which clown will step up to the plate with a moronic response?
I need a good laugh today!
Get ready for the bad news this week and the crash back to trips.
This says it all!
The payment services in the US is powered by NIUM Inc. and the program is sponsored by CFSB to which NIUM is a service provider. HUMBL is not licensed, nor exempt to provide any payment services in the US
I don.t encourage the trading in scams. Thus none! LOL
Very true. I piss on scammers! LOL Thanks!
Dragging out the same bullshit for years is beyond comical.
Flapping lips either way is meaningless.
If Sharp had a merger lined up he would have paid off Calasse and moved on it!
Not rocket science.
Watch out! The a hole will sue you for hurting his company by posting facts! LOL
He is a grade A loser!